An Observational Study of Patients With Malignant Lymphomas Treated With MabThera® SC in Everyday Clinical Practice

Clinical trial NCT02240316 · COMPLETED

Trial details

NCT number: NCT02240316
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Lymphoma, B-Cell, Lymphoma, Follicular

Start date: 2014-07-08
Primary completion: 2019-07-22
Enrollment: 688

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.